25.10.2014 Views

Full text PDF - International Policy Network

Full text PDF - International Policy Network

Full text PDF - International Policy Network

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Corruption in public health 89<br />

by under-trained medical students operating on patients without<br />

supervision (Lewis, La Forgia and Sulvetta, 1992).<br />

Staff accountability for misconduct is rare. Its absence in<br />

accountability is noted for the Dominican Republic (La Forgia et al.,<br />

2004), although Cohen (2002) reports that in Costa Rica 27 per cent<br />

of users know of a case where sanctions were imposed or a public<br />

employee was terminated for corruption or theft. So there are some<br />

countries where at least egregious misconduct is disciplined.<br />

Collusion among public officials has also been identified as perpetuating<br />

corruption. In Bosnia and Herzegovina (World Bank,<br />

2001e) 35 per cent of officials said health colleagues who refuse<br />

bribes face retribution, and similar views were expressed in focus<br />

group discussions among public health staff in Ethiopia.<br />

Supplies: mismanagement and corruption<br />

Availability of drugs and supplies complement health professionals<br />

and their absence reflect poor management or corruption.<br />

Drug management and leakage<br />

Virtually all qualitative studies that have probed this issue have<br />

emerged with the view that quality and drug availability are virtually<br />

synonymous, and lack of drugs has been repeatedly shown to<br />

discourage utilization of public facilities (World Bank, 2005a). A<br />

recent in depth assessment of the Costa Rican pharmaceutical<br />

system’s registration, drug selection, procurement, distribution and<br />

service delivery revealed both great strengths and glaring weaknesses.<br />

The study used a combination of (i) interviews with public<br />

officials; (ii) industry interviews with local pharmacies and multinational<br />

companies; (iii) focus groups with health care professionals;<br />

and, (iv) exit surveys for a representative sample of patients.<br />

Clear publicly available procedures, pharmaceutical lists and<br />

criteria; reliance on defined, generic drugs; and distribution audits<br />

were deemed excellent. The greatest weaknesses were in procurement,<br />

specifically in the lack of performance monitoring, quality<br />

monitoring, audits and uncontrolled political interference; and in

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!